Literature DB >> 9112419

Functional interactions between neuronal AT1 and AT2 receptors.

C H Gelband1, M Zhu, D Lu, L P Reagan, S J Fluharty, P Posner, M K Raizada, C Sumners.   

Abstract

Angiotensin II (Ang II), via the activation of the AT1 and AT2 receptors regulates electrophysiological responses of catecholaminergic neurons. This study was designed to determine if functional interactions between AT1 and AT2 receptors exist in a single neuron. Ang II caused two unique electrophysiological responses characteristic of receptor crosstalk. First, Ang II elicited an AT1 receptor-mediated decrease in I(K) followed by an AT2 receptor-mediated increase in I(K). Second, Ang II elicited an AT2 receptor-mediated increase in I(K) followed by an AT1 receptor-mediated decrease in I(K). AT1 and AT2 receptors were co-localized on the catecholaminergic neurons. These observations suggest, for the first time, the existence of a crosstalk between Ang II receptor subtypes that may be significant in the physiological activity of catecholaminergic neurons.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9112419     DOI: 10.1210/endo.138.5.5236

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  20 in total

Review 1.  Novel actions of angiotensin II via its renal type-2 (AT(2)) receptor.

Authors:  R M Carey; Z Q Wang; H M Siragy
Journal:  Curr Hypertens Rep       Date:  1999 Apr-May       Impact factor: 5.369

2.  AT-1 receptor and phospholipase C are involved in angiotensin III modulation of hypothalamic noradrenergic transmission.

Authors:  M Rodriguez-Campos; C Kadarian; V Rodano; L Bianciotti; B Fernandez; M Vatta
Journal:  Cell Mol Neurobiol       Date:  2000-12       Impact factor: 5.046

3.  Aging, Angiotensin system and dopaminergic degeneration in the substantia nigra.

Authors:  Jose L Labandeira-Garcia; Jannette Rodriguez-Pallares; Begoña Villar-Cheda; Ana I Rodríguez-Perez; Pablo Garrido-Gil; Maria J Guerra
Journal:  Aging Dis       Date:  2011-04-20       Impact factor: 6.745

4.  Sustained hypersensitivity to angiotensin II and its mechanism in mice lacking the subtype-2 (AT2) angiotensin receptor.

Authors:  H M Siragy; T Inagami; T Ichiki; R M Carey
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

5.  Brain angiotensin and dopaminergic degeneration: relevance to Parkinson's disease.

Authors:  Jose L Labandeira-Garcia; Jannette Rodriguez-Pallares; Ana I Rodríguez-Perez; Pablo Garrido-Gil; Begoña Villar-Cheda; Rita Valenzuela; Maria J Guerra
Journal:  Am J Neurodegener Dis       Date:  2012-11-18

6.  Increased angiotensin II AT1 receptor mRNA and binding in spleen and lung of AT2 receptor gene disrupted mice.

Authors:  Jaroslav Pavel; José A Terrón; Julius Benicky; Alicia Falcón-Neri; Amita Rachakonda; Tadashi Inagami; Juan M Saavedra
Journal:  Regul Pept       Date:  2009-09-17

7.  Imbalance of angiotensin type 1 receptor and angiotensin II type 2 receptor in the rostral ventrolateral medulla: potential mechanism for sympathetic overactivity in heart failure.

Authors:  Lie Gao; Wei-Zhong Wang; Wei Wang; Irving H Zucker
Journal:  Hypertension       Date:  2008-09-02       Impact factor: 10.190

8.  Glucose mediates transcriptional repression of the human angiotensin type-1 receptor gene: role for a novel cis-acting element.

Authors:  Beena E Thomas; Thomas J Thekkumkara
Journal:  Mol Biol Cell       Date:  2004-07-21       Impact factor: 4.138

9.  Angiotensin II AT(1) receptor blockade selectively enhances brain AT(2) receptor expression, and abolishes the cold-restraint stress-induced increase in tyrosine hydroxylase mRNA in the locus coeruleus of spontaneously hypertensive rats.

Authors:  C Bregonzio; A Seltzer; I Armando; J Pavel; J M Saavedra
Journal:  Stress       Date:  2008-11       Impact factor: 3.493

10.  A peripherally administered, centrally acting angiotensin II AT2 antagonist selectively increases brain AT1 receptors and decreases brain tyrosine hydroxylase transcription, pituitary vasopressin and ACTH.

Authors:  Miroslava Macova; Jaroslav Pavel; Juan M Saavedra
Journal:  Brain Res       Date:  2008-11-12       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.